The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study.

Huang Luwen; Mei Lijun; Li Linlin; Yu Ming

doi:10.1002/brb3.71299

March 1, 2026

The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study.

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research examines the association between the C-reactive protein-triglyceride glucose index and the risk of developing chronic diseases.
Conducted a longitudinal cohort study
Monitored participants for new-onset chronic diseases
Analyzed the relationship between CTI, chronic disease onset, and clinical outcomes
Elevated CTI is linked to a higher risk of chronic diseases
Significant predictive value of CTI as a biomarker
CTI may serve as a valuable tool in clinical risk assessment

Implication

Longitudinal cohort study finds that elevated CTI predicts new-onset chronic diseases, indicating its clinical value.

Abstract

Elevated CTI is strongly associated with an increased risk of several chronic diseases, highlighting its potential value as a clinical risk assessment tool and predictive biomarker.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Luwen et al. (2026) studied this question.

synapsesocial.com/papers/69a67ed1f353c071a6f0a55c https://doi.org/10.1002/brb3.71299

View at Publisher

Ask AI

Bookmark

Share

The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study.

Key Points

Implication

Abstract

Discussion

Cite This Study

The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study.

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers